Author

J Q Cheng

Observed names: J Cheng, J. Cheng, Ji-Wen Cheng, Ji‐wen Cheng

Institutions: Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University

Observed institutions: Fox Chase Cancer Center, Guangxi Medical University, Fudan University, Bristol-Myers Squibb (United States), First Affiliated Hospital of GuangXi Medical University, New York University

ORCID: 0000-0001-5557-8633

Observed ORCID: 0000-0001-5557-8633

OpenAlex ID: A5101556331

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

1992 · J Q Cheng, A K Godwin, et al. · Proceedings of the National Academy of Sciences · 737

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

1995 · A B Bianchi, S I Mitsunaga, et al. · Proceedings of the National Academy of Sciences · 360

Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer

2023 · Hai‐qi Liang, Nai‐kai Liao, et al. · International Journal of Urology · 4

Gene Deletion in Urothelium by Specific Expression of Cre Recombinase

2006 · L. Mo, J. Cheng, et al. · The Journal of Urology · 4

Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-β Signaling-Mediated Anti-PD-L1 Response in Bladder Cancer

2026 · Hai-Qi Liang, Yu-Jian Li, et al. · ImmunoTargets and Therapy

[Cloning and sequence analysis of activated protein kinase C receptor gene of Leishmania major].

2001 · J Cheng, X B Xia, et al. · PubMed

Works count: 6

Citation count: 1,105

H-index: 4

I10-index: 2